Revvity (NYSE:RVTY) Price Target Lowered to $125.00 at Robert W. Baird

Revvity (NYSE:RVTY) had its target price lowered by equities researchers at Robert W. Baird from $129.00 to $125.00 in a research note issued on Monday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s price objective indicates a potential upside of 44.08% from the company’s previous close.

A number of other research analysts also recently issued reports on the stock. Weiss Ratings downgraded shares of Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 18th. Evercore upped their price target on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research note on Tuesday, February 3rd. TD Cowen reaffirmed a “hold” rating on shares of Revvity in a research note on Tuesday, February 3rd. JPMorgan Chase & Co. lowered their price target on Revvity from $105.00 to $96.00 and set a “neutral” rating for the company in a research note on Tuesday, March 31st. Finally, Barclays reaffirmed an “equal weight” rating and issued a $95.00 price target (down from $118.00) on shares of Revvity in a research note on Tuesday, April 14th. Three equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $109.36.

Revvity Stock Performance

Revvity stock opened at $86.76 on Monday. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. Revvity has a 1 year low of $81.22 and a 1 year high of $118.30. The company has a market cap of $9.70 billion, a PE ratio of 41.71, a PEG ratio of 1.85 and a beta of 1.05. The company’s 50-day moving average is $90.39 and its two-hundred day moving average is $96.82.

Revvity (NYSE:RVTY) last released its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The company had revenue of $772.06 million for the quarter, compared to the consensus estimate of $759.81 million. During the same period in the prior year, the company posted $1.42 EPS. The company’s revenue was up 5.9% compared to the same quarter last year. Equities analysts anticipate that Revvity will post 5.39 earnings per share for the current year.

Institutional Trading of Revvity

Large investors have recently bought and sold shares of the business. Ascentis Independent Advisors bought a new stake in Revvity during the 1st quarter worth approximately $29,000. CYBER HORNET ETFs LLC bought a new stake in Revvity during the 2nd quarter worth approximately $32,000. Cromwell Holdings LLC increased its stake in Revvity by 141.4% during the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after purchasing an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new stake in Revvity during the 2nd quarter worth approximately $34,000. Finally, Headlands Technologies LLC bought a new stake in Revvity during the 2nd quarter worth approximately $49,000. 86.65% of the stock is owned by institutional investors.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.